Evoke Pharma Inc (STU:EV00)
€ 0.398 -0.014 (-3.4%) Market Cap: 3.72 Mil Enterprise Value: -610,000.00 PE Ratio: 0 PB Ratio: 0 GF Score: 38/100

Q1 2021 Evoke Pharma Inc Earnings Call Transcript

May 12, 2021 / 08:30PM GMT
Release Date Price: €15.36 (+4.92%)
Operator

Good afternoon, and thank you for joining Evoke Pharma's First Quarter 2021 Earnings Conference Call. I would now like to introduce Christine Petraglia for opening remarks.

Christine Petraglia
The Ruth Group, Inc. - SVP of IR

Good afternoon, and welcome to Evoke Pharma's First Quarter 2021 Earnings Conference Call and Audio Webcast. With me today are Dave Gonyer, Evoke's Chief Executive Officer; and Matt D'Onofrio, Chief Business Officer; as well as Chris Quesenberry from EVERSANA as GIMOTI's Chief Commercial Officer.

Earlier today, Evoke issued a press release announcing financial results for the first quarter ended March 31, 2021. We encourage everyone to read today's press release as well Evoke's quarterly report on Form 10-Q, which is filed with the SEC. The company's 10-Q report and press release are also available on Evoke's website at www.evokepharma.com.

In addition, this conference call is being webcast through the company's website and will be archived to 30 days

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot